Citichem India Limited Plans Rs 136.3 Crore Warrant Issue, EGM Scheduled for December 15

2 min read     Updated on 23 Nov 2025, 07:07 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Citichem India Limited announces a preferential issue of 4.7 million convertible warrants at Rs 29.00 each, aiming to raise Rs 136.30 crore. The company will seek shareholder approval at an EGM on December 15, 2025. Funds will be used for working capital, corporate purposes, and capex. Post-issue, promoter shareholding is expected to increase from 61.21% to 73.59%, while public shareholding will decrease from 38.79% to 26.41%. The company's balance sheet shows a 175.34% increase in shareholders' capital and a 19.48% decrease in current liabilities over the past year.

25450672

*this image is generated using AI for illustrative purposes only.

Citichem India Limited (ISIN: INE0A8401016) has announced plans for a significant capital raise through a preferential issue of convertible warrants. The company has scheduled an Extra-ordinary General Meeting (EGM) on December 15, 2025, to seek shareholder approval for this strategic move.

Key Details of the Proposed Warrant Issue

Aspect Details
Number of Warrants 4.7 million
Issue Price per Warrant Rs 29.00
Total Fund Raise Rs 136.30 crore
Allottees Promoters and others
Issue Type Preferential basis

Objectives of the Fund Raise

The company intends to utilize the proceeds for:

  1. Working capital requirements
  2. General corporate purposes
  3. Capital expenditure (Capex)

Impact on Shareholding Pattern

Shareholder Category Pre-Issue Holding Post-Issue Holding
Promoter & Promoter Group 61.21% 73.59%
Public 38.79% 26.41%

This warrant issue is expected to significantly increase the promoter shareholding in the company.

Financial Position

An analysis of Citichem India's balance sheet reveals some interesting trends:

Metric Current Year (2025-03) 1 Year Ago (2024-03) Change
Total Assets Rs 69.90 crore Rs 69.30 crore +0.87%
Shareholders' Capital Rs 20.10 crore Rs 7.30 crore +175.34%
Current Assets Rs 62.30 crore Rs 69.10 crore -9.84%
Current Liabilities Rs 49.20 crore Rs 61.10 crore -19.48%

The company has seen a substantial increase in shareholders' capital over the past year, while maintaining a relatively stable asset base. The reduction in current liabilities suggests improved financial health, although this has been accompanied by a decrease in current assets.

Implications and Outlook

The proposed warrant issue represents a significant move for Citichem India Limited. If approved, it will substantially strengthen the company's capital base and provide funds for growth initiatives. The increased promoter stake could also signal strong confidence in the company's future prospects.

However, shareholders should carefully consider the dilution effect on their holdings, particularly for public shareholders whose overall stake in the company is set to decrease. The company's ability to effectively utilize the raised funds for growth and value creation will be crucial in justifying this capital restructuring.

Investors and stakeholders are advised to review the detailed terms of the warrant issue and consider the company's growth strategy before making investment decisions. The upcoming EGM on December 15, 2025, will be a key event to watch for further developments on this corporate action.

Historical Stock Returns for Citichem

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+4.00%-10.03%-17.46%-61.92%-61.92%
like20
dislike

Citichem Shareholders Approve Share Capital Increase and Rs 131.6 Crore Convertible Warrant Issue

1 min read     Updated on 01 Oct 2025, 07:58 AM
scanx
Reviewed by
Riya DScanX News Team
Overview

Citichem's shareholders approved key proposals at the 33rd AGM, including an increase in authorized share capital from Rs 75 crore to Rs 125 crore and the issuance of 4.7 million convertible warrants at Rs 28 each, totaling Rs 131.60 crore. The warrants will be issued to promoters and non-promoters, subject to regulatory clearances. The AGM also addressed standard agenda items and offered both physical and remote e-voting options.

20831340

*this image is generated using AI for illustrative purposes only.

Citichem has secured crucial shareholder approvals at its 33rd Annual General Meeting (AGM) held on September 30, paving the way for significant capital restructuring and fund-raising initiatives.

Key Approvals

Authorized Share Capital Increase

Shareholders have given their nod to increase the company's authorized share capital from Rs 75.00 crore to Rs 125.00 crore. This move is expected to provide Citichem with greater flexibility in its capital structure and future fundraising efforts.

Convertible Warrant Issue

The AGM also approved the issuance of up to 4.7 million convertible warrants at Rs 28.00 per warrant, amounting to a total of Rs 131.60 crore. These warrants will be convertible into equity shares with a face value of Rs 10.00 each.

Warrant Allotment Details

The convertible warrants will be issued on a preferential basis to both promoters and non-promoter entities. The proposed allottees include:

  • Arif Esmail Merchant
  • Hashim Arif Merchant
  • Fozia Arif Merchant
  • Saima Hashim Merchant
  • Padmakar Jagannath Murodiya

Regulatory Compliance

Citichem has emphasized that both approvals are subject to necessary regulatory clearances. The company has made the required disclosures in compliance with SEBI regulations, including adherence to the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.

AGM Proceedings

The AGM, which took place at the Imperial Lounge (NSCI) in Mumbai, also addressed other standard agenda items:

  • Adoption of audited financial statements for the year ended March 31
  • Re-appointment of Mr. Hashim Arif Merchant (DIN: 03015945) as a director, who was retiring by rotation

The meeting was conducted with both physical presence and remote e-voting options available to shareholders, ensuring wide participation in the decision-making process.

Management Commentary

Arif Esmail Merchant, Managing Director of Citichem, signed off on the regulatory filings, indicating the management's commitment to transparency and compliance with listing obligations.

These strategic decisions signal Citichem's intent to strengthen its financial position and potentially fuel future growth initiatives.

Historical Stock Returns for Citichem

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+4.00%-10.03%-17.46%-61.92%-61.92%
like19
dislike
More News on Citichem
Explore Other Articles
26.00
0.0
(0.0%)